Atig, Juvy .

HRN: 11-60-96  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2023
CEFUROXIME 1.5GM (VIAL)
01/17/2023
01/18/2023
IV
1.5 G
Q8 X 2 Doses
Sp Ltcs For Malpresentation
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: